Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Resistance To Vorinostat In Hematological Malignancies May Involve Cytoprotective UPR and Correlates With Increased Sensitivity To Bortezomib-Induced Cell Death

Daphné Dupéré-Richer, Ph.D candidate, Mena Kinal, M.Sc., Filippa Pettersson, Ph.D, Wilson H. Miller, Jr., MD, PhD

Blood (2013) 122 (21): 5137.

https://doi.org/10.1182/blood.V122.21.5137.5137

Published: 2013

Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD

Blood (2013) 122 (21): 821.

https://doi.org/10.1182/blood.V122.21.821.821

Published: 2013

Journal Articles

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Sarit Assouline, MD, Biljana Kraljacic-Culjkovic, PhD, Eftihia Cocolakis, PhD, Abdellatif Amri, Julie Bergeron, MD, Rahima Jamal, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB Borden, PhD

Blood (2011) 118 (21): 3606.

https://doi.org/10.1182/blood.V118.21.3606.3606

Published: 2011

Journal Articles

Targeting EVI1-Overexpressing AML with Darinaparsin

Koren K Mann, PhD, Nathalie Johnson, MD, Torsten Holm Nielsen, MD, Nicolas Garnier, MSc, Stanley Kwan, Eftihia Cocolakis, PhD, Josee Hebert, MD, Robert Morgan, MSc, Wilson H. Miller, Jr., MD, PhD

Blood (2011) 118 (21): 4269.

https://doi.org/10.1182/blood.V118.21.4269.4269

Published: 2011

Journal Articles

Darinaparsin a Novel Organic Arsenic Molecule Active in Lymphoma: Development of An Oral Form.

Wilson H. Miller, Jr., MD, PhD, Izidore S. Lossos, MD, PhD, Paul R. Conkling, MD, Carlos Becerra, MD, Martin S. Tallman, MD, Jill Buck, Barbara Wallner, PhD, Jonathan Lewis, MD, PhD

Blood (2009) 114 (22): 4759.

https://doi.org/10.1182/blood.V114.22.4759.4759

Published: 2009

Journal Articles

Trolox Improves the Sensitivity of Multiple Myeloma to Arsenic Trioxide in Vitro and In Vivo.

Michael Sebag, MD, PhD, Xian-Fang Huang, Nicolas Garnier, Wilson H. Miller, Jr., MD, PhD, Koren Mann, PhD

Blood (2009) 114 (22): 4920.

https://doi.org/10.1182/blood.V114.22.4920.4920

Published: 2009

Journal Articles

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Sarit E. Assouline, MD, Eftihia Cocolakis, PhD, Caroline Rousseau, PhD, Biljana Culjkovic, PhD, Nathalie Beslu, PhD, Abdellatif Amri, Stephen N. Caplan, MD, Brian Leber, MD, Denis-Claude Roy, MD, Katherine L. B. Borden, PhD, Wilson H. Miller, Jr., MD, PhD

Blood (2009) 114 (22): 2085.

https://doi.org/10.1182/blood.V114.22.2085.2085

Published: 2009

Journal Articles

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, Katherine L. B. Borden

Blood (2009) 114 (2): 257–260.

https://doi.org/10.1182/blood-2009-02-205153

Published: 2009

Includes: Supplemental data

Journal Articles

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

Guillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, Zeev Estrov, Hagop Kantarjian, Hui Yang, Willie M. Newsome, Wilson H. Miller, Jr, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, Tracy-Ann Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory Reid, Eric Laille, Robert E. Martell, Mark Minden

Blood (2008) 112 (4): 981–989.

https://doi.org/10.1182/blood-2007-10-115873

Published: 2008

Includes: Supplemental data

Journal Articles

Epigenomic repression by APL oncoprotein

Filippa Pettersson, Wilson H. Miller, Jr

Blood (2008) 111 (5): 2498.

https://doi.org/10.1182/blood-2007-12-128074

Published: 2008

Journal Articles

Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines

Zuanel Diaz, Myrian Colombo, Koren K. Mann, Haixiang Su, Kamilah N. Smith, D. Scott Bohle, Hyman M. Schipper, Wilson H. Miller, Jr

Blood (2005) 105 (3): 1237–1245.

https://doi.org/10.1182/blood-2004-05-1772

Published: 2005

Journal Articles

Expression of SMRTβ promotes ligand-induced activation of mutated and wild-type retinoid receptors

Sylvie Côté, Suzan McNamara, Daria Brambilla, Andrea Bianchini, Giovanni Rizzo, Sonia Victoria del Rincón, Francesco Grignani, Clara Nervi, Wilson H. Miller, Jr

Blood (2004) 104 (13): 4226–4235.

https://doi.org/10.1182/blood-2003-10-3583

Published: 2004

Journal Articles

Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells

Michael Witcher, Hoi Ying Shiu, Qi Guo, Wilson H. Miller, Jr

Blood (2004) 104 (10): 3335–3342.

https://doi.org/10.1182/blood-2004-01-0023

Published: 2004

Journal Articles

JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells

Kelly Davison, Koren K. Mann, Samuel Waxman, Wilson H. Miller, Jr

Blood (2004) 103 (9): 3496–3502.

https://doi.org/10.1182/blood-2003-05-1412

Published: 2004

Journal Articles

Synergy between all- trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells

Michael Witcher, Douglas T. Ross, Caroline Rousseau, Leslie Deluca, Wilson H. Miller, Jr

Blood (2003) 102 (1): 237–245.

https://doi.org/10.1182/blood-2002-09-2725

Published: 2003

Journal Articles

Response to histone deacetylase inhibition of novel PML/RARα mutants detected in retinoic acid–resistant APL cells

Sylvie Côté, Angelika Rosenauer, Andrea Bianchini, Karen Seiter, Jonathan Vandewiele, Clara Nervi, Wilson H. Miller, Jr

Blood (2002) 100 (7): 2586–2596.

https://doi.org/10.1182/blood-2002-02-0614

Published: 2002

Journal Articles

Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

Joseph G. Jurcic, Stephen D. Nimer, David A. Scheinberg, Tony DeBlasio, Raymond P. Warrell, Jr, Wilson H. Miller, Jr

Blood (2001) 98 (9): 2651–2656.

https://doi.org/10.1182/blood.V98.9.2651

Published: 2001

Journal Articles

Combined effect of all- trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

Yongkui Jing, Long Wang, Lijuan Xia, Guo-qiang Chen, Zhu Chen, Wilson H. Miller, Samuel Waxman

Blood (2001) 97 (1): 264–269.

https://doi.org/10.1182/blood.V97.1.264

Published: 2001

Journal Articles

Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia

Sylvie Côté, Dacheng Zhou, Andrea Bianchini, Clara Nervi, Robert E. Gallagher, Wilson H. Miller, Jr

Blood (2000) 96 (9): 3200–3208.

https://doi.org/10.1182/blood.V96.9.3200

Published: 2000

Journal Articles

Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid–sensitive and –resistant acute promyelocytic leukemia cells

Wenlin Shao, Angelika Rosenauer, Koren Mann, Chao-Pei Betty Chang, Christophe Rachez, Leonard P. Freedman, Wilson H. Miller, Jr

Blood (2000) 96 (6): 2233–2239.

https://doi.org/10.1182/blood.V96.6.2233

Published: 2000

NARROW

Resistance To Vorinostat In Hematological Malignancies May Involve Cytoprotective UPR and Correlates With Increased Sensitivity To Bortezomib-Induced Cell Death

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,

Targeting EVI1-Overexpressing AML with Darinaparsin

Darinaparsin a Novel Organic Arsenic Molecule Active in Lymphoma: Development of An Oral Form.

Trolox Improves the Sensitivity of Multiple Myeloma to Arsenic Trioxide in Vitro and In Vivo.

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

Epigenomic repression by APL oncoprotein

Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines

Expression of SMRTβ promotes ligand-induced activation of mutated and wild-type retinoid receptors

Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells

JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells

Synergy between all- trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells

Response to histone deacetylase inhibition of novel PML/RARα mutants detected in retinoic acid–resistant APL cells

Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

Combined effect of all- trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia

Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid–sensitive and –resistant acute promyelocytic leukemia cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only